Differential expression and localization of decorin in human choriodecidual membrane during preterm and term pregnancy

American Journal of Reproductive Immunology

Volumn 51, Issue 3, 2004, Pages 204-210

  Ogita, Kazuhide ^a   Kimura, Tadashi ^a   Nakamura, Hitomi ^a   Koyama, Shinsuke ^a   Tsujie, Tomoko ^a   Tomiie, Mari ^a   Tsutsui, Tateki ^a   Shimoya, Koichiro ^a   Wada, Yoshinao ^a   Koyama, Masayasu ^a   Nomura, Shintaro ^a   Murata, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Decidua; Decorin; Feto maternal interface; Parturition

Indexed keywords

COMPLEMENTARY DNA; DECORIN; MESSENGER RNA;

ARTICLE; CESAREAN SECTION; CHILDBIRTH; CONTROLLED STUDY; DECIDUA; DNA ISOLATION; DNA LIBRARY; ELECTIVE SURGERY; FEMALE; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOLECULAR CLONING; MOTHER FETUS RELATIONSHIP; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UPREGULATION; VAGINAL DELIVERY;

EID: 11144354670     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2004.00143.x     Document Type: Article

References (30)

1. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III (eds): Williams Obstetrics, 19th edn. Stamford, Appleton & Lange, pp. 261-317.
2. Slater D, Dennes W, Sawdy R, Allport V, Bennett P: Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999; 22:125-130.
3. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdolv ED, Siebert PD: Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 1996; 93:6025-6030.
4. Hocking AM, Shinomura T, McQuillan DJ: Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998; 17:1-19.
5. Vogel KG, Paulsson M, Heinegard D: Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223:587-597.
6. Schmidt G, Hausser H, Kresse H: Interaction of the small proteoglycan decorin with fibronectin. Biochem J 1991; 280:411-414.
7. Kimura T, Azuma C, Saji F, Takemura M, Tokugawa Y, Miki M, Ono M, Mori K, Tanizawa O: Estimation by an electrophysiological method of the expression of oxytocin receptor mRNA in human myometrium during pregnancy. J Steroid Biochem Mol Biol 1992; 42:253-258.
8. Takemura M, Nomura S, Kimura T, Inoue T, Onoue H, Azuma C, Saji F, Kitamura Y, Tanizawa O: Expression and localization of oxytocin receptor gene in human uterine endometrium in relation to the menstrual cycle. Endocrinology 1993; 132:1830-1835.
9. Pulkkinen L, Alitalo T, Krusius T, Peltonen L: Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN). Cytogenet Cell Genet 1992; 60:107-111.
10. Rechberger T, Wossener JF: Collagenase, its inhibitors, and decorin in the lower uterine segment in pregnant women. Am J Obstet Gynecol 1993; 168:1598-1603.
11. Westergren-Thorsson G, Norman M, Bjornsson S, Endresen U, Stjernholm Y, Ekman G, Malmstrom A: Differential expression of mRNA for proteoglycans, collagens and transforming growth factor-β in the human cervix during pregnancy and involution. Biochemica et Biophysica Acta 1998; 1406:203-213.
12. Lysiak JJ, Pringle GA, Lala PK: Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 1995; 16:221-231.
13. Meinert M, Eriksen V, Petersen A, Helmig RB, Laurent C, Uldbjerg N, Malmstrom A: Proteoglycans and hyaluronan in human fetal membranes. Am J Obstet Gynecol 2001; 184:679-685.
14. Wu W-X, Zhang Q, Unno N, Derks JB, Nathanilesz PW: Characterization of decorin mRNA in pregnant intrauterine tissues of the ewe and regulation by steroids. Am J Physiol 2000; 278:C199-C206.
15. Li X, Massa P, Hanidu A, Peet G, Aro P, Savitt A, Mische S, Li J, Marcu K: IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J Biol Chem 2002; 277:45,129-45,140.
16. Nakamura H, Kimura T, Ogita K, Nakamura T, Takemura M, Shimoya K, Koyama S, Tsujie T, Koyama M, Murata Y: NF kappa B activation at implantation window of the mouse uterus. Am J Reprod Immunol 2004; in press.
17. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I: Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999; 274:4489-4492.
18. Gargiulo AR, Khan-Dawood FS, Dawood MY: Epidermal growth factor receptors in uteroplacental tissues in term pregnancy before and after the onset of labor. J Clin Endocrinol Metab 1997; 82:113-117.
19. Tahara M, Masumoto N, Mizuki J, Kasahara K, Tasaka K, Kurachi H, Miyake A: Roles of prostaglandins and intracellular free calcium mobilisation in epidermal growth factor-induced proliferation of human amnion cells. BJOG 1994; 101:894-900.
20. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 1990; 346:281-284.
21. Graham CH, Lysiak JJ, McCrae KR, Lala PK: Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992; 46:561-572.
22. Lang AK, Searle RF: The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 (TGF-β1) and beta 2 activity. Clin Exp Immunol 1994; 97:158-163.
23. Hatthachote P, Morgan J, Dunlop W, Europe-Finner GN, Gillespie JI: Gestational changes in the levels of transforming growth factor-β1 and TGF-β receptor types I and II in the human myometrium. J Clin Endocrinol Metab 1998; 83:2987-2992.
24. Clark DA, Flanders KC, Banwatt D, Millar-Book W, Manuel J, Stedronska-Clark J, Rowley B: Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor β -1. J Immunol 1990; 144:3008-3014.
25. Clark DA, Vince G, Flanders KC, Hirte H, Starkey P: CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming factor-β2-related immunosuppressive factors. Hum Reprod 1994; 9:2270-2277.
26. Gu J, Nakayama Y, Nagai K, Wada Y: The production and purification of functional decorin in a baculovirus system. Biochem Biophys Res Commun 1997; 232:91-95.
27. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature 1992; 360:361-364.
28. Masuda H, Takakura Y, Hashida M: Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice. Biochemca et Biophysica Acta 1999; 1426:420-428.
29. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997; 136:729-743.
30. Kimura T, Ogita K, Kusui C, Ohashi K, Azuma C, Murata Y: What knockout mice can tell us about parturition. Reviews of Reproduction 1999; 4:73-80.